TABLE 3.

Predicted factors for the development of fatigue in patients with PD.

		Occurrence of fatigue
		OR	95%CI	P-value
From baseline to 1-year (n = 113)	UPDRS III	1.051	1.010–1.094	0.015*
From baseline to 2-year (n = 111)	LEDD	1.002	1.000–1.005	0.037*
From baseline to 3-year (n = 84)	LEDD	1.003	1.000–1.005	0.049*
	HAMA	1.077	1.003–1.157	0.042*

PD, Parkinson’s disease; UPDRS, Unified Parkinson’s Disease Rating Scale; LEDD, levodopa equivalent daily dose; HAMA, Hamilton Anxiety Rating Scale. *Significant difference.